#USA #St. Paul #iotaMotion #cochlear implant #iotaSOFT

iotaMotion Surpasses 1,000 Clinical Procedures

In a remarkable achievement for the field of auditory health, iotaMotion, Inc., a leader in robotic technology for cochlear implantation, has recently performed over 1,000 clinical procedures utilizing the innovative iotaSOFT® Insertion System. This milestone not only signifies the increasing acceptance of robotic-assisted surgical methods but also highlights the crucial benefits this technology offers for patients and surgeons alike.

Transformative Technology in Surgical Procedures

The iotaSOFT system stands out as the first and only FDA-authorized robotic-assisted cochlear implant insertion system available in the United States. What sets it apart is its ability to provide enhanced precision, consistency, and control during one of the most delicate parts of cochlear implant surgery — the electrode array insertion. This advanced approach represents a significant departure from traditional manual techniques and aims at preserving vital cochlear structures while minimizing trauma.

"The iotaSOFT system is a game changer in cochlear implant surgery, enabling procedures that go beyond the limitations of human capabilities," said Mike Lobinsky, CEO of iotaMotion, during an announcement regarding the significant milestone. "Our technology standardizes the insertion process and broadens patients' access to these life-altering implants."

An Urgent Need for Cochlear Implants

Despite the clear advantages of cochlear implants, the World Health Organization estimates that less than 5% of eligible patients globally currently receive them. With over 430 million individuals suffering from disabling hearing loss, the need for effective solutions is more pressing than ever. Factors contributing to this low adoption rate include misinformation about candidacy, fears related to surgery, and unrealistic expectations concerning outcomes.

Moreover, emerging research has shown that untreated hearing loss is linked to an increased risk of dementia, accounting for approximately 8% of cases globally — a figure that surpasses that attributed to hypertension, obesity, or smoking. The iotaSOFT system addresses both technological and emotional barriers associated with the procedure by enabling confidence among patients and improving clinical outcomes.

Improved Patient Outcomes with Robotics

Clinical studies have shown promising results regarding the use of robotic technology in cochlear implantation. A study published in The Laryngoscope has demonstrated that patients undergoing robotic-assisted electrode array insertion experienced higher rates of hearing preservation compared to traditional methods; 85% maintained their residual hearing at one-year post-surgery, versus 71% for manual insertion techniques.

Experts in the field have praised the precision and control that the iotaSOFT system brings to surgeries. Dr. Michael Seidman from AdventHealth noted, "This technology allows me to carry out electrode array insertions with unprecedented accuracy, reducing risks of inner ear trauma significantly."

Dr. Eric Kraus from Atrium Health echoed these sentiments, emphasizing the value that robotics adds to his practice. "The iotaSOFT system has become essential for us, and as we approach 100 insertions, the consistent benefits we've seen speak volumes about its effectiveness."

The Future of Cochlear Implant Surgery

As iotaMotion continues to demonstrate the potential of robotic technology in cochlear implant surgery, the company remains committed to educating healthcare providers and increasing awareness about cochlear implants and their substantial benefits. With iotaSOFT being actively integrated into esteemed cochlear implant centers across the United States and undergoing clinical evaluation in other markets, the future looks promising.

In summary, iotaMotion’s milestone of reaching 1,000 clinical procedures with its iotaSOFT® system marks a pivotal moment not just for the company, but for the future of auditory health. The intersection of advanced technology and patient-centered care stands ready to transform how hearing loss is addressed worldwide.